UnknownPhase 3

Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores

Thailand16 participantsStarted 2024-02-28

Plain-language summary

The purpose of this study is to assess the efficacy and safety of microneedle patch with botulinum toxin for improving enlarged pores.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * At least 18 years old and concerned about enlarged pores * Have pore size 0.3-0.6 mm * Have pore parameter in each other side of faces not different more than 5% Exclusion Criteria: * Any neuromuscular condition * Pregnancy or breast feeding * History of allergy : Botulinum toxin, topical anesthesia * History of keloid or hypertrophic scar * History of coagulation or receiving medication that causes coagulation disorder * Using drugs that have interaction with Botulinum toxin * Using topical medication that improves enlarged pores in 1 month * Taking medication that improves enlarged pores in 1 month * Receiving the laser/treatment/chemical peeling in 6 months

What they're measuring

Change from baseline of enlarged pores as measured by VISIA (pores parameter) and using pore score

Timeframe: Post-intervention, week 4 and week 16

Trial details

NCT IDNCT06293755

SponsorDhurakij Pundit University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03-05

View on ClinicalTrials.gov More Enlarged Pores trials